Trust Company of Kansas’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-186,821
Closed -$4.53M 63
2025
Q2
$4.53M Sell
186,821
-3,600
-2% -$84K 2.16% 21
2025
Q1
$4.83M Sell
190,421
-5,355
-3% -$140K 2.57% 18
2024
Q4
$5.19M Sell
195,776
-4,579
-2% -$124K 2.49% 19
2024
Q3
$5.8M Sell
200,355
-6,260
-3% -$183K 2.82% 16
2024
Q2
$5.78M Buy
206,615
+197,914
+2,275% +$5.45M 3.02% 14
2024
Q1
$241K Sell
8,701
-2,015
-19% -$55.9K 0.13% 45
2023
Q4
$309K Hold
10,716
0.17% 39
2023
Q3
$355K Buy
10,716
+15
+0.1% +$530 0.23% 32
2023
Q2
$393K Buy
10,701
+411
+4% +$16K 0.24% 32
2023
Q1
$420K Sell
10,290
-728
-7% -$31.4K 0.27% 31
2022
Q4
$565K Hold
11,018
0.37% 31
2022
Q3
$482K Sell
11,018
-592
-5% -$28.8K 0.34% 27
2022
Q2
$609K Sell
11,610
-6,288
-35% -$320K 0.36% 29
2022
Q1
$927K Buy
17,898
+265
+2% +$13.8K 0.5% 24
2021
Q4
$1.04M Sell
17,633
-3,619
-17% -$179K 0.55% 27
2021
Q3
$914K Sell
21,252
-2,574
-11% -$114K 0.52% 24
2021
Q2
$933K Buy
23,826
+4,328
+22% +$168K 0.53% 22
2021
Q1
$706K Buy
19,498
+2,400
+14% +$85.2K 0.46% 24
2020
Q4
$629K Sell
17,098
-792
-4% -$29.1K 0.33% 29
2020
Q3
$623K Buy
17,890
+10,744
+150% +$377K 0.32% 33
2020
Q2
$222K Hold
7,146
0.12% 44
2020
Q1
$221K Buy
7,146
+518
+8% +$17.7K 0.13% 52
2019
Q4
$246K Buy
+6,628
New +$236K 0.14% 39

Other funds holding PFE

Trust Company of Kansas's PFE Position: Q3 2025 in Review

Trust Company of Kansas sold out of Pfizer (PFE) in Q3 2025, closing a stake of 186,821 shares — an estimated $4.53M sold.

Trust Company of Kansas first reported a position in PFE in Q4 2019 and held it in 23 quarters. The position peaked at $5.8M in Q3 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Trust Company of Kansas reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Trust Company of Kansas sold 186,821 Pfizer shares in Q3 2025, an estimated $4.53M.
  • Trust Company of Kansas first reported a position in Pfizer in Q4 2019 and held it in 23 quarters.
  • Trust Company of Kansas's Pfizer position peaked at $5.8M in Q3 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Trust Company of Kansas's 13F filing for Q3 2025, filed 14 Nov 2025.